Showing 1–3 of 3 results for author: Hamidinekoo, A

Utilizing Weak-to-Strong Consistency for Semi-Supervised Glomeruli Segmentation

Authors: Irina Zhang, Jim Denholm, Azam Hamidinekoo, Oskar Ålund, Christopher Bagnall, Joana Palés Huix, Michal Sulikowski, Ortensia Vito, Arthur Lewis, Robert Unwin, Magnus Soderberg, Nikolay Burlutskiy, Talha Qaiser

Abstract: Accurate segmentation of glomerulus instances attains high clinical significance in the automated analysis of renal biopsies to aid in diagnosing and monitoring kidney disease. Analyzing real-world histopathology images often encompasses inter-observer variability and requires a labor-intensive process of data annotation. Therefore, conventional supervised learning approaches generally achieve sub… ▽ More Accurate segmentation of glomerulus instances attains high clinical significance in the automated analysis of renal biopsies to aid in diagnosing and monitoring kidney disease. Analyzing real-world histopathology images often encompasses inter-observer variability and requires a labor-intensive process of data annotation. Therefore, conventional supervised learning approaches generally achieve sub-optimal performance when applied to external datasets. Considering these challenges, we present a semi-supervised learning approach for glomeruli segmentation based on the weak-to-strong consistency framework validated on multiple real-world datasets. Our experimental results on 3 independent datasets indicate superior performance of our approach as compared with existing supervised baseline models such as U-Net and SegFormer. △ Less

Submitted 30 May, 2024; originally announced June 2024.

Comments: accepted to MIDL'24

Interpretable histopathology-based prediction of disease relevant features in Inflammatory Bowel Disease biopsies using weakly-supervised deep learning

Authors: Ricardo Mokhtari, Azam Hamidinekoo, Daniel Sutton, Arthur Lewis, Bastian Angermann, Ulf Gehrmann, Pal Lundin, Hibret Adissu, Junmei Cairns, Jessica Neisen, Emon Khan, Daniel Marks, Nia Khachapuridze, Talha Qaiser, Nikolay Burlutskiy

Abstract: Crohn's Disease (CD) and Ulcerative Colitis (UC) are the two main Inflammatory Bowel Disease (IBD) types. We developed deep learning models to identify histological disease features for both CD and UC using only endoscopic labels. We explored fine-tuning and end-to-end training of two state-of-the-art self-supervised models for predicting three different endoscopic categories (i) CD vs UC (AUC=0.8… ▽ More Crohn's Disease (CD) and Ulcerative Colitis (UC) are the two main Inflammatory Bowel Disease (IBD) types. We developed deep learning models to identify histological disease features for both CD and UC using only endoscopic labels. We explored fine-tuning and end-to-end training of two state-of-the-art self-supervised models for predicting three different endoscopic categories (i) CD vs UC (AUC=0.87), (ii) normal vs lesional (AUC=0.81), (iii) low vs high disease severity score (AUC=0.80). We produced visual attention maps to interpret what the models learned and validated them with the support of a pathologist, where we observed a strong association between the models' predictions and histopathological inflammatory features of the disease. Additionally, we identified several cases where the model incorrectly predicted normal samples as lesional but were correct on the microscopic level when reviewed by the pathologist. This tendency of histological presentation to be more severe than endoscopic presentation was previously published in the literature. In parallel, we utilised a model trained on the Colon Nuclei Identification and Counting (CoNIC) dataset to predict and explore 6 cell populations. We observed correlation between areas enriched with the predicted immune cells in biopsies and the pathologist's feedback on the attention maps. Finally, we identified several cell level features indicative of disease severity in CD and UC. These models can enhance our understanding about the pathology behind IBD and can shape our strategies for patient stratification in clinical trials. △ Less

Submitted 16 May, 2023; v1 submitted 20 March, 2023; originally announced March 2023.

Comments: Accepted to the Medical Imaging with Deep Learning (MIDL'23)

Glioma Classification Using Multimodal Radiology and Histology Data

Authors: Azam Hamidinekoo, Tomasz Pieciak, Maryam Afzali, Otar Akanyeti, Yinyin Yuan

Abstract: Gliomas are brain tumours with a high mortality rate. There are various grades and sub-types of this tumour, and the treatment procedure varies accordingly. Clinicians and oncologists diagnose and categorise these tumours based on visual inspection of radiology and histology data. However, this process can be time-consuming and subjective. The computer-assisted methods can help clinicians to make… ▽ More Gliomas are brain tumours with a high mortality rate. There are various grades and sub-types of this tumour, and the treatment procedure varies accordingly. Clinicians and oncologists diagnose and categorise these tumours based on visual inspection of radiology and histology data. However, this process can be time-consuming and subjective. The computer-assisted methods can help clinicians to make better and faster decisions. In this paper, we propose a pipeline for automatic classification of gliomas into three sub-types: oligodendroglioma, astrocytoma, and glioblastoma, using both radiology and histopathology images. The proposed approach implements distinct classification models for radiographic and histologic modalities and combines them through an ensemble method. The classification algorithm initially carries out tile-level (for histology) and slice-level (for radiology) classification via a deep learning method, then tile/slice-level latent features are combined for a whole-slide and whole-volume sub-type prediction. The classification algorithm was evaluated using the data set provided in the CPM-RadPath 2020 challenge. The proposed pipeline achieved the F1-Score of 0.886, Cohen's Kappa score of 0.811 and Balance accuracy of 0.860. The ability of the proposed model for end-to-end learning of diverse features enables it to give a comparable prediction of glioma tumour sub-types. △ Less

Submitted 10 November, 2020; originally announced November 2020.